Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥34.8b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Imeik Technology DevelopmentLtd

Market Cap: CN¥54.6b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

Darya-Varia Laboratoria

Market Cap: Rp1.8t

Manufactures and trades pharmaceutical products and cosmetics in Indonesia.

R&G PharmaStudies

Market Cap: CN¥5.0b

Operates as a clinical trial outsourcing service provider in China and internationally.

Maxigen Biotech

Market Cap: NT$3.7b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Kalbe Farma

Market Cap: Rp52.9t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Tyche Industries

Market Cap: ₹1.4b

Manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally.

Y-Biologics

Market Cap: ₩208.1b

An antibody new drug development platform company, engages in the research and development of immuno-oncology drugs and antibody drugs.

Suzhou Fushilai Pharmaceutical

Market Cap: CN¥3.1b

Engages in the manufacture and sale of biopharmaceutical products in China.

Hanall Biopharma

Market Cap: ₩1.6t

A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.

Landfar Bio-medicine

Market Cap: CN¥3.1b

Operates as a biomedical technology company.

Accent Microcell

Market Cap: ₹5.3b

Manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally.

Shouyao Holdings (Beijing)

Market Cap: CN¥7.1b

Engages in the research, development, and production of pharmaceutical drugs in China.

Jiangsu Hengrui Medicine

Market Cap: CN¥481.8b

A pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.

Firebrick Pharma

Market Cap: AU$15.7m

Engages in the development and commercializing of formulations for the uses of povidone iodine in Australia, the United states and Singapore.

Tiansheng Pharmaceutical Group

Market Cap: CN¥1.6b

Engages in the pharmaceutical manufacturing and circulation activities.

ChemPartner PharmaTechLtd

Market Cap: CN¥6.0b

Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide.

EyeGene

Market Cap: ₩66.2b

Engages in the research and development of biopharmaceutical drugs for the treatment and prevention of age-related diseases in South Korea.

StemCyte International

Market Cap: NT$4.7b

Operates cord blood cell banks in the United States and Taiwan.

Formosa Pharmaceuticals

Market Cap: NT$4.6b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

Tourmaline Bio

Market Cap: US$1.2b

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Applied Therapeutics

Market Cap: US$67.0m

A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.

Kamada

Market Cap: ₪1.3b

Manufactures and sells plasma-derived protein therapeutics.

Atossa Therapeutics

Market Cap: US$106.6m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

Nurix Therapeutics

Market Cap: US$665.1m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Lytix Biopharma

Market Cap: NOK 491.5m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

Onco-Innovations

Market Cap: CA$98.8m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Barinthus Biotherapeutics

Market Cap: US$48.0m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

Trevi Therapeutics

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

Concord Biotech

Market Cap: ₹170.5b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹3.9t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Eagle Veterinary TechnologyLtd

Market Cap: ₩54.4b

Manufactures and sells animal health care products.

Avecho Biotechnology

Market Cap: AU$22.2m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Changzhou Qianhong BiopharmaLTD

Market Cap: CN¥11.5b

Manufactures and distributes polysaccharide and protease drugs in China.

Monopar Therapeutics

Market Cap: US$450.7m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Boundless Bio

Market Cap: US$25.6m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).